Thogoto virus ML protein is a potent inhibitor of the interferon regulatory factor-7 transcription factor

Nico Buettner1, Carola Vogt, Luis Martínez-Sobrido

  • 1Abteilung Virologie, Universität Freiburg, D-79008 Freiburg, Germany.

Insights

Thogoto virus (THOV) ML protein suppresses host interferon (IFN) immunity. ML inhibits IFN induction by blocking interferon regulatory factor (IRF) activation, revealing its role as a viral virulence factor.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Thogoto virus (THOV) is a tick-borne orthomyxovirus.
  • THOV possesses a viral suppressor of the RNA virus-sensing interferon (IFN) system, the ML protein.
  • Understanding viral immune evasion mechanisms is crucial for antiviral strategies.

Purpose of the Study:

  • To investigate the role of the THOV ML protein in suppressing the host type I IFN response.
  • To elucidate the molecular mechanism by which ML antagonizes IFN induction.
  • To identify the specific host factors targeted by ML.

Main Methods:

  • Infection of primary mouse embryo fibroblasts and plasmacytoid dendritic cells with wild-type and ML-deficient THOV.
  • Reporter gene assays to measure IFN regulatory factor (IRF) activation (IRF3 and IRF7).
  • Co-immunoprecipitation assays to study protein-protein interactions between ML and IRF7, and TRAF6.
  • Analysis of IRF7 nuclear translocation.

Main Results:

  • THOV lacking ML strongly induces type I IFN, while wild-type THOV suppresses it.
  • ML inhibits reporter gene expression dependent on IRF3 and IRF7.
  • ML directly interacts with IRF7, preventing its dimerization and association with TRAF6.
  • ML does not affect the nuclear translocation of IRF7.

Conclusions:

  • The THOV ML protein is a key virulence factor that antagonizes the host type I IFN response.
  • ML specifically targets IRF family members, inhibiting their activation upstream of nuclear translocation.
  • ML acts by preventing IRF7 dimerization and subsequent TRAF6 association, thereby suppressing IFN induction.

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...